Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.

Also called NCT02096406

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 126 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02096406
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02096406. Randomized; no masking; primary purpose treatment. Start 2014-04 (registry gives no type); primary completion 2018-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass
Acronym
COMPACT
Intervention (Drug)
ACE/ARB continuation
Intervention (Drug)
ACE/ARB withdrawal
Lead sponsor
University of Alberta (class: other)

Record details

Record id
cardio:ct-nct02096406
Content hash
97e15ab824bc031eaaf5d01fcb6bb23702903870e6f4a7382f58c0a02fe4aec1